BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32883228)

  • 1. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.
    Zhao J; Zhang W; Zhang J; Zhang Y; Ma WJ; Liu SY; Li FY; Song B
    BMC Cancer; 2020 Sep; 20(1):849. PubMed ID: 32883228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.
    Chen P; Li B; Zhu Y; Chen W; Liu X; Li M; Duan X; Yi B; Wang J; Liu C; Luo X; Li X; Li J; Liang L; Yin X; Wang H; Jiang X
    Oncotarget; 2016 Jun; 7(24):37319-37330. PubMed ID: 27144432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma: Limited Improvement Compared with the 7th Staging System.
    Lee JW; Lee JH; Park Y; Lee W; Kwon J; Song KB; Hwang DW; Kim SC
    Cancer Res Treat; 2020 Jul; 52(3):886-895. PubMed ID: 32164049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
    Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
    Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma.
    Ruzzenente A; Bagante F; Ardito F; Campagnaro T; Scoleri I; Conci S; Iacono C; Giuliante F; Guglielmi A
    Surgery; 2018 Aug; 164(2):244-250. PubMed ID: 29801730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma.
    Spolverato G; Bagante F; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    J Surg Oncol; 2017 May; 115(6):696-703. PubMed ID: 28194791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and external validation of a nomogram for predicting the effect of tumor size on survival of patients with perihilar cholangiocarcinoma.
    Zhang Y; Wu Z; Wang X; Li C; Chang J; Jiang W; Wang H; Wang Y; Li X
    BMC Cancer; 2020 Oct; 20(1):1044. PubMed ID: 33126868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the New American Joint Committee on Cancer Staging Manual 8th Edition for Perihilar Cholangiocarcinoma.
    Gaspersz MP; Buettner S; van Vugt JLA; de Jonge J; Polak WG; Doukas M; Ijzermans JNM; Koerkamp BG; Willemssen FEJA
    J Gastrointest Surg; 2020 Jul; 24(7):1612-1618. PubMed ID: 30756314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suggestions for improving perihilar cholangiocarcinoma staging based on an evaluation of the seventh edition AJCC system.
    Kwon W; Jang JY; Chang YR; Jung W; Kang MJ; Kim SW
    J Gastrointest Surg; 2015 Apr; 19(4):666-74. PubMed ID: 25572971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching.
    Noji T; Tsuchikawa T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Shichinohe T; Hirano S
    J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):442-8. PubMed ID: 27207604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma.
    Geers J; Jaekers J; Topal H; Aerts R; Vandoren C; Vanden Boer G; Topal B
    World J Surg Oncol; 2020 Nov; 18(1):286. PubMed ID: 33143698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis.
    Tang Z; Yang Y; Zhao Z; Wei K; Meng W; Li X
    Medicine (Baltimore); 2018 Aug; 97(34):e11999. PubMed ID: 30142840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Klatskin tumor: long-term survival following surgery].
    Juntermanns B; Fingas CD; Sotiropoulos GC; Jaradat D; Dechêne A; Reis H; Kasper S; Paul A; Kaiser GM
    Chirurg; 2016 Jun; 87(6):514-9. PubMed ID: 27090415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
    Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
    Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal indications for additional resection of the invasive cancer-positive proximal bile duct margin in cases of advanced perihilar cholangiocarcinoma.
    Oguro S; Esaki M; Kishi Y; Nara S; Shimada K; Ojima H; Kosuge T
    Ann Surg Oncol; 2015; 22(6):1915-24. PubMed ID: 25404474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes.
    Conci S; Ruzzenente A; Sandri M; Bertuzzo F; Campagnaro T; Bagante F; Capelli P; D'Onofrio M; Piccino M; Dorna AE; Pedrazzani C; Iacono C; Guglielmi A
    Eur J Surg Oncol; 2017 Apr; 43(4):743-750. PubMed ID: 28094085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma.
    Peng D; Lu J; Hu H; Li B; Ye X; Cheng N
    J Gastrointest Surg; 2020 Feb; 24(2):330-340. PubMed ID: 30671792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of Prognostic Schemes for Perihilar Cholangiocarcinoma.
    Buettner S; van Vugt JL; Gani F; Groot Koerkamp B; Margonis GA; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Guglielmi A; IJzermans JN; Pawlik TM
    J Gastrointest Surg; 2016 Oct; 20(10):1716-24. PubMed ID: 27412318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.
    Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    Surgery; 2018 Apr; 163(4):732-738. PubMed ID: 29336813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.